<DOC>
	<DOCNO>NCT00659776</DOCNO>
	<brief_summary>The purpose study address safety efficiency new iron particle contrast agent , ferumoxytol . This product may useful view vessel brain area brain magnetic resonance imaging ( MRI ) , magnetic resonance angiography ( MRA ) , standard substance , gadolinium , inject MRI MRA . Other way ferumoxytol may help include follow : 1 . Ferumoxytol may provide ability well see inflammatory lesion magnetic resonance imaging ( MRI ) scan 2 . Ferumoxytol may useful ability cross blood vessel inflammatory process , 3 . Ferumoxytol , size ability get area next inflammatory lesion could assist treatment inflammatory lesion association cardiac surgery CNS vascular surgery .</brief_summary>
	<brief_title>MR , Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System ( CNS ) Inflammation</brief_title>
	<detailed_description>Subjects recruit patient one neurology , neurosurgery , neuro-oncology , Multiple Sclerosis Clinic cardiothoracic surgery clinic OHSU . Eligible subject enrol different group base disease ( MS , cardiac surgery CNS vascular surgery , stroke ) . Subsequently MRI MRA brain use standard contrast agent ( Gadolinium ) obtain ; study compare ferumoxytol-contrasted MRA MRIs perform next day ( ) . Visit 1 : subject enrol distributed correspond group ; also basic laboratory study obtain well Gadolinium contrast MRI MRA brain . For Groups 1 2 ( MS Stroke ) : Visit 2 : Ferumoxytol inject i.v . bolus . The total dose 2 hour exceed 510mg , divide multiple small dose 1 mg Fe/kg optimize MRA imaging may dilute 4 fold normal saline reduce T2* effect MR angiography . Visit 3 : 24 hour second visit MRI standard contrast agent do . Last visit : 1 month Ferumoxytol administration , subject reassess physical laboratory exam . For Groups 3 4 ( Cardiac surgery CNS vascular surgery ) : After screen visit ( Visit 1 ) baseline MRI MRA randomly assign one two group . These group similar slight difference schedule event . - Group 3a 4a : ferumoxytol infusion ( Visit 2 ) surgery - Group 3b 4b : ferumoxytol infusion ( Visit 2 ) surgery Visit 2 : Ferumoxytol inject i.v . bolus . The total dose 2 hour exceed 510mg , divide multiple small dose 1 mg Fe/kg optimize MRA imaging may dilute 4 fold normal saline reduce T2* effect MR angiography . Visit 3 : 24-72 hour second visit MRI standard contrast agent do . Last visit : 1 month Ferumoxytol administration , subject reassess physical laboratory exam .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Ferrosoferric Oxide</mesh_term>
	<criteria>Subjects must clinical , radiological establish histological diagnosis multiple sclerosis , stroke , require cardiac CNS vascular surgery . Subjects CNS inflammatory lesion suspicious neoplasm radiation induce inflammation ( vasculitis ) also include ( group 1a ) . McDonald 's criterion use diagnosis multiple sclerosis . Subjects must 18 year old Subjects follow least 1 month infusion ferumoxytol . All subject authorize representative must sign write informed consent give HIPAA authorization accordance institutional guideline . Female subject childbearing potential must postmenopausal , surgically sterile , use reliable form contraception least month . These criterion wave discretion investigator onemonth wait require best interest patient . Karnofsky must 30 % great Subjects clinically significant sign uncal herniation Subjects contraindication MRI : metal body ( cardiac pacemaker incompatible device ) , severely agitate , allergy Gd contrast material . Subjects know allergic hypersensitivity reaction parenteral iron , parenteral dextran , parenteral irondextran , parenteral ironpolysaccharide preparation Subjects know hepatic insufficiency cirrhosis Subjects know suspect iron overload HIVpositive subject combination antiretroviral therapy ineligible potential pharmacokinetic interaction ferumoxytol Pregnant lactate woman exclude study possible risk fetus infant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>ferumoxytol</keyword>
</DOC>